SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

FDA Approves Novartis Cosentyx for Polymyalgia Rheumatica

The approval adds a new FDA-approved treatment option for people with polymyalgia rheumatica.

Related stories